University of Toronto, Ontario Institute for Cancer Research (OICR), National Scientific Director and Lead of CanPath
Toronto, Ontario
Joined April 2017
- Tweets310
- Following221
- Followers403
- Likes621
Awadalla Lab retweeted
First plenary session talk by Marie-Julie Fave on mosaic chromosomal abnormalities in blood across ancestries #ASHG24
Awadalla Lab retweeted
“Rather than say using invasive approaches… blood samples like plasma or serum capture the signature of a cancer somewhere in the body… In many cases we can detect those signatures up to 7 years before [a #cancer diagnosis].” – Dr. Philip Awadalla, Director at OICR
Awadalla Lab retweeted
Registration for the next CanPath trainee research webinar is live! Join @mp_harwood and Umaimah Zanif as they showcase how CanPath data can be used to explore how age, lifestyle factors, and the environment affect gene and biomarker expression.
bit.ly/CanPathTraineeWebinar…
ALT Trainee research webinar poster
Awadalla Lab retweeted
Congratulations, @NancyGenetics! From Scientific Director @AwadallaLab, "Nancy has been an instrumental advisor on CanPath's Int'l Scientific Advisory Board. Her impact as a researcher and leadership as a geneticist have been a cornerstone to CanPath's success on a global scale."
Congratulations 🏆 to ASHG Lifetime Achievement Awardee Neil Risch, PhD @UCSF, and ASHG Leadership Awardee Nancy Cox, PhD @VUMC_Medicine, for your contributions to genetics and genomics! #ASHG23
ALT Neil Risch, PhD, accepting the ASHG Lifetime Achievement Award at the 2023 Annual Meeting.
ALT Nancy Cox, PhD, accepting the ASHG Leadership Award at the 2023 Annual Meeting.
Awadalla Lab retweeted
Congratulations to our own Nicholas Cheng from OICR for his First Prize winning poster at the Early Detection of Cancer Conference in London UK!!
Awadalla Lab retweeted
OHS participant Matt asks: How does our blood change as we age?
Find out from cancer researcher Dr. @KimSkead how our blood acts as an early messenger of emerging health issues, and why platforms like the OHS are important to the early detection of cancer & chronic disease.
In celebration of #ScienceLiteracyWeek, we present our latest Ask a Cancer Researcher video. Here, Dr. @KimSkead answers the question of how our blood changes as we age and how that factors into predicting, diagnosing and treating cancer.
#cancerresearch @scilitweek
Awadalla Lab retweeted
Panel Discussion: Chairs @HeidiRehm & @PersonalizedMed lead a discussion at @AGBT Precision Health 2023 with polls on the great debate, genetics, environment & health with @GaryWMiller3 from @Columbia, @AwadallaLab from @CanPath & Alison Motsinger-Reif from @NIEHS #AGBTPH
Awadalla Lab retweeted
Don't miss The Great Debate!
Join us for a once-in-a-generation conversation about the root causes of genetic mutations. You won't want to miss this!
Register for AGBT Precision Health 2023 today: rebrand.ly/Register-AGBT-PH
Awadalla Lab retweeted
#UofT researchers contribute to Canada-wide COVID-19 immunity study 🔬 uoft.me/9y9
Awadalla Lab retweeted
🔬🦠 Boosting Immunity Insights: New research led by @COVIDimmunityTF, with contributions from CanPath, reveals Canada's evolving immunity landscape in the first pan-Canadian seroprevalence study!
🔗 canpath.ca/2023/08/covid-ser…
SARS-CoV-2 seroprevalence:
Most people in Canada were infected with SARS-CoV-2 for the first time during the Omicron era, after previously being vaccinated.
Learn more (and earn CPD credits) ➡️ cmaj.ca/lookup/doi/10.1503/c…
#COVID19
ALT Given variations in population seropositivity by age and geography, the potential for waning antibody levels, and new variants that may escape immunity, public health policy and clinical decisions should be tailored to local patterns of population immunity.
Awadalla Lab retweeted
Working with @AwadallaLab at OICR helped @UofT PhD candidate Tom Ouellette turn an interest in computational biology into a passion for #research that impacts #cancer patients
See what Tom's working on in our latest The Next Generation video📽️
Awadalla Lab retweeted
The Next Generation: @nickwfcheng, PhD candidate in @AwadallaLab, is using OHS & @CanPath data to look for #biomarkers in the blood that could be used to detect breast, prostate and pancreatic cancers several years before a traditional diagnosis.
buff.ly/3NGEm1J
Awadalla Lab retweeted
📢 Our COVID-19 Antibody Study found that 53% of the #COVID19 diagnoses were among those who neither knew, nor suspected, they had been infected! Check out Dr. Victoria Kirsh’s findings in her @CanPath webinar. @AwadallaLab @KimSkead
buff.ly/3XsVlc6
Awadalla Lab retweeted
🎥 Discover the latest insights on COVID-19 vaccines and risk factors from our recorded event, from undetected COVID-19 cases to vaccine effectiveness against Omicron and the protection offered by prior infection. 📺 youtube.com/watch?v=65ixV_WJ…
ALT Dr. Victoria Kirsh at the podium
ALT Dr. Victoria Kirsh presenting SARS-CoV-2 seroprevalence findings.
ALT Dr. Philip Awadalla and Dr. Victoria Kirsh during the Q&A.
Awadalla Lab retweeted
A recent @NatureComms paper by @inofechm, Dr. @david_soave, Dr. Philip Awadalla (@AwadallaLab) and Dr. Sagi Abelson has been selected as an Editors' Highlight. 👏
nature.com/articles/s41467-0…
Awadalla Lab retweeted
We spot @CanPath National Scientific Director, Dr. Philip Awadalla (@AwadallaLab) at @GenomeCanada's meeting about #genomics and #PrecisionHealth.
#HealthResearch #CanPath #Cohort
Pleased to welcome colleagues from across the Canadian Genomics Enterprise and health #genomics ecosystem to Montreal for a rich and candid conversation to help shape our impact in #PrecisionHealth. 🧬
#CanadasGenomicsFuture
ALT Meeting participants watching a presentation
ALT Group shot of meeting participants
Awadalla Lab retweeted
🔍 Ever wondered how time since vaccination affects your protection against #COVID19? 🤔 Register for our event on May 30th with Dr. Victoria Kirsh, where she will present the latest findings from the SUPPORT-Canada study: bit.ly/CanPathCOVIDEN
ALT Event banner
Awadalla Lab retweeted
Want to stay ahead of the curve on COVID-19 vaccine effectiveness? Join Dr. Victoria Kirsh from the Ontario Health Study for a hybrid event on May 30th, where she'll share insights from CanPath's SUPPORT-Canada study. Register now: bit.ly/CanPathCOVIDEN
ALT Webinar banner
Awadalla Lab retweeted
The Next Generation: @nickwfcheng, PhD candidate in @AwadallaLab, is using OHS and @CanPath data to look for #biomarkers in the blood that could be used to detect breast, prostate and pancreatic cancers several years before a traditional diagnosis.
buff.ly/3oCsC7n
Awadalla Lab retweeted
Only by combining #HealthData from across the country can we get large enough sample sizes for certain #RareDiseases & large data studies could lead to new treatments for rare diseases. - @AwadallaLab @CanPath #GenomicsForum2023
